An Evaluation of the Impact of Pharmacist Comprehensive Medication Management With Pharmacogenomic Results to Improve Depression Outcomes in Community Pharmacies.
Recruiting
N/A
Interventional Study
Pharmacogenetics
Depression - Major Depressive Disorder
Pharmacogenomic Drug Interaction
Community Pharmacy Services
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 220 (estimated)
- Sponsor
- University of Pittsburgh · Other
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The goal of this prospective, randomized clinical trial is to learn whether pharmacogenomic (PGx)-guided comprehensive medication management delivered by pharmacists in community pharmacies will improve antidepressant treatment outcomes.
The primary aim is to determine whether comprehensive medication management with review of PGx testing results improves depression symptoms, compared with usual …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
INCLUSION CRITERIA:
* At targeted community pharmacy for:
* New prescription or change in dose/schedule of SSRI (citalopram, escitalopram, sertraline, paroxetine), OR
* Concurrent SSRI (citalopram, escitalopram, sertraline, paroxetine) and new prescription/change in SNRI (desvenlafaxine, dulox…
Contacts